Carbon Monoxide Therapy for Severe Pulmonary Arterial Hypertension (CO in PAH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01523548
Recruitment Status : Withdrawn (Lack of funding and subject acuity)
First Posted : February 1, 2012
Last Update Posted : June 9, 2017
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Roberto Machado, M.D., University of Illinois at Chicago

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : December 2018
  Estimated Study Completion Date : December 2018